Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Myasthenia Gravis 5Strabismus 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Emergence Delirium 1Autoimmune Diseases 1

Interventions

telitacicept 2Prednisone 2Blood Specimen Collection 2thymoglobulin 1remdesivir 1prednylidene 1fludarabine 1deltacortene 1carmustine, poliferprosan 20 drug combination 1apremilast 1Vitamin D 1Valsartan 1Telemedicine 1Surveys and Questionnaires 1Standard of Care 1Specimen Handling 1Pyridostigmine Bromide 1Practice Guidelines as Topic 1Population Groups 1Peripheral Blood Stem Cell Transplantation 1Nivolumab 1Mycophenolic Acid 1Music Therapy 1Methods 1Melphalan 1Mastectomy, Segmental 1Mammaplasty 1Interviews as Topic 1Infliximab 1Immunotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Autoimmune Diseases × Pyridostigmine Bromide × Clear all
NCT06723548 2024-12-09

Telitacicept and Low-dose Steroids in Refractory Myasthenia Gravis

First Affiliated Hospital of Wenzhou Medical University

Phase 4 Not yet recruiting
30 enrolled

Autoimmune Diseases, Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡